Vinpocetine improves brain energy and blood supply and has been
used as a preventative and as a treatment for stroke and other
brain injury. It acts as a cerebral metabolic activator, which
may improve cerebral circulation and enhance oxygen and glucose
utilization in the brain. Vinpocetine may diminish, or reduce,
disturbances due to hypoxia, or to deficient cerebral metabolism.
It has been noted to improve oxygen and glucose utilization by
brain cells and increase their resistance to damage by hypoxia.
Vinpocetine's anti-aging benefits may include prevention and
treatment of stroke and other brain injuries, improved aged conditions
caused by poor brain blood circulation, particularly eyesight
and hearing, improved concentration, treatment and alleviation
of the problems of menopause and increased potential life span.
Pharmacology: Synonyms: AY-27255; Ethyl Apovincaminate; Ethyl
Apovincaminoate; Chemical Name: Ethyl (3alpha,16alphaeburnamenine-14-carboxylate.
Molecular Formula: C(22)H(26)N(2) O(2) Molecular Weight: 350.5
CAS Registry: 42971-09-5.
Side Effects and Contraindications: Side effects are rate, but
may include nausea, eruption and individual hypersensitivity.
Patients thought to be in complete homeostasis after cerebral
hemorrhage should avoid Vinpocetine. Although only applicable
to high doses, if hypersensitive signs occur, discontinue use.
Distribution: Vinpocetine is available in 1mg, 5mg and 10mg tablets
under the trade names Cavinton, Remedial, and Vincaton.
Note: Vinpocetine shows many of the positive signs of a preventative
Back to Anti-Aging